InvestorsHub Logo
Followers 1
Posts 44
Boards Moderated 0
Alias Born 03/30/2021

Re: None

Tuesday, 04/19/2022 7:35:00 AM

Tuesday, April 19, 2022 7:35:00 AM

Post# of 50667
$MCET what is most frustrating about this company is that its patent (Fa2N-4) is being actively used but to no benefit of the investor. The below article was published in April 2022 regarding bile acid research. You can find the reference to Fa2N-4 in all below articles with a control-F search.
https://www.frontiersin.org/articles/10.3389/fmars.2022.861117/full

See article published March 2022 of this year where it is used for liver cancer research for proof.
https://www.mdpi.com/1420-3049/27/7/2219/htm

Another article published in March where it is used in another research project.
https://onlinelibrary.wiley.com/doi/full/10.53365/efood.k/146945